BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cozma D, Yu D, Hodawadekar S, Azvolinsky A, Grande S, Tobias JW, Metzgar MH, Paterson J, Erikson J, Marafioti T, Monroe JG, Atchison ML, Thomas-Tikhonenko A. B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling. J Clin Invest 2007;117:2602-10. [PMID: 17717600 DOI: 10.1172/JCI30842] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Ahmed MB, Nabih ES, Al-sheeha M. PAX5α and PAX5β mRNA expression in breast Cancer: Relation to serum P53 and MMP2. Egyptian Journal of Medical Human Genetics 2017;18:289-94. [DOI: 10.1016/j.ejmhg.2017.01.001] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
2 Zhong F, Harr MW, Bultynck G, Monaco G, Parys JB, De Smedt H, Rong YP, Molitoris JK, Lam M, Ryder C, Matsuyama S, Distelhorst CW. Induction of Ca²+-driven apoptosis in chronic lymphocytic leukemia cells by peptide-mediated disruption of Bcl-2-IP3 receptor interaction. Blood 2011;117:2924-34. [PMID: 21193695 DOI: 10.1182/blood-2010-09-307405] [Cited by in Crossref: 92] [Cited by in F6Publishing: 92] [Article Influence: 7.7] [Reference Citation Analysis]
3 McGrath-Morrow SA, Ndeh R, Helmin KA, Khuder B, Rothblum-Oviatt C, Collaco JM, Wright J, Reyfman PA, Lederman HM, Singer BD. DNA methylation and gene expression signatures are associated with ataxia-telangiectasia phenotype. Sci Rep 2020;10:7479. [PMID: 32366930 DOI: 10.1038/s41598-020-64514-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Bouamar H, Abbas S, Lin AP, Wang L, Jiang D, Holder KN, Kinney MC, Hunicke-Smith S, Aguiar RC. A capture-sequencing strategy identifies IRF8, EBF1, and APRIL as novel IGH fusion partners in B-cell lymphoma. Blood 2013;122:726-33. [PMID: 23775715 DOI: 10.1182/blood-2013-04-495804] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
5 Wang Q, Fang WH, Krupinski J, Kumar S, Slevin M, Kumar P. Pax genes in embryogenesis and oncogenesis. J Cell Mol Med 2008;12:2281-94. [PMID: 18627422 DOI: 10.1111/j.1582-4934.2008.00427.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 94] [Article Influence: 6.3] [Reference Citation Analysis]
6 Ott CJ, Federation AJ, Schwartz LS, Kasar S, Klitgaard JL, Lenci R, Li Q, Lawlor M, Fernandes SM, Souza A, Polaski D, Gadi D, Freedman ML, Brown JR, Bradner JE. Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia. Cancer Cell 2018;34:982-995.e7. [PMID: 30503705 DOI: 10.1016/j.ccell.2018.11.001] [Cited by in Crossref: 46] [Cited by in F6Publishing: 35] [Article Influence: 11.5] [Reference Citation Analysis]
7 Gentles AJ, Alizadeh AA, Lee SI, Myklebust JH, Shachaf CM, Shahbaba B, Levy R, Koller D, Plevritis SK. A pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients. Blood 2009;114:3158-66. [PMID: 19636063 DOI: 10.1182/blood-2009-02-202465] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
8 Jahangiri L, Tsaprouni L, Trigg RM, Williams JA, Gkoutos GV, Turner SD, Pereira J. Core regulatory circuitries in defining cancer cell identity across the malignant spectrum. Open Biol 2020;10:200121. [PMID: 32634370 DOI: 10.1098/rsob.200121] [Reference Citation Analysis]
9 Bougel S, Renaud S, Braunschweig R, Loukinov D, Morse HC 3rd, Bosman FT, Lobanenkov V, Benhattar J. PAX5 activates the transcription of the human telomerase reverse transcriptase gene in B cells. J Pathol 2010;220:87-96. [PMID: 19806612 DOI: 10.1002/path.2620] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
10 Schneider D, Manzan MA, Crawford RB, Chen W, Kaminski NE. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a. J Pharmacol Exp Ther 2008;326:463-74. [PMID: 18483191 DOI: 10.1124/jpet.108.139857] [Cited by in Crossref: 35] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
11 Donnou S, Galand C, Touitou V, Sautès-Fridman C, Fabry Z, Fisson S. Murine models of B-cell lymphomas: promising tools for designing cancer therapies. Adv Hematol 2012;2012:701704. [PMID: 22400032 DOI: 10.1155/2012/701704] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
12 Chung EY, Psathas JN, Yu D, Li Y, Weiss MJ, Thomas-Tikhonenko A. CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis. J Clin Invest. 2012;122:2257-2266. [PMID: 22546857 DOI: 10.1172/jci45851] [Cited by in Crossref: 53] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
13 Narayansingh R, Ouellette RJ. Paired box gene 5 may modulate Proviral Integration of Moloney virus 2 gene and protein expression in mature B-cells. Leuk Lymphoma 2011;52:887-95. [PMID: 21299464 DOI: 10.3109/10428194.2011.553001] [Reference Citation Analysis]
14 Murn J, Alibert O, Wu N, Tendil S, Gidrol X. Prostaglandin E2 regulates B cell proliferation through a candidate tumor suppressor, Ptger4. J Exp Med 2008;205:3091-103. [PMID: 19075289 DOI: 10.1084/jem.20081163] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 3.3] [Reference Citation Analysis]
15 Murn J, Mlinaric-Rascan I, Vaigot P, Alibert O, Frouin V, Gidrol X. A Myc-regulated transcriptional network controls B-cell fate in response to BCR triggering. BMC Genomics 2009;10:323. [PMID: 19607732 DOI: 10.1186/1471-2164-10-323] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
16 Chung EY, Dews M, Cozma D, Yu D, Wentzel EA, Chang TC, Schelter JM, Cleary MA, Mendell JT, Thomas-Tikhonenko A. c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA cluster. Cancer Biol Ther 2008;7:1758-64. [PMID: 18708755 DOI: 10.4161/cbt.7.11.6722] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
17 Lee N, Moss WN, Yario TA, Steitz JA. EBV noncoding RNA binds nascent RNA to drive host PAX5 to viral DNA. Cell 2015;160:607-18. [PMID: 25662012 DOI: 10.1016/j.cell.2015.01.015] [Cited by in Crossref: 97] [Cited by in F6Publishing: 91] [Article Influence: 13.9] [Reference Citation Analysis]
18 Psathas JN, Doonan PJ, Raman P, Freedman BD, Minn AJ, Thomas-Tikhonenko A. The Myc-miR-17-92 axis amplifies B-cell receptor signaling via inhibition of ITIM proteins: a novel lymphomagenic feed-forward loop. Blood 2013;122:4220-9. [PMID: 24169826 DOI: 10.1182/blood-2012-12-473090] [Cited by in Crossref: 48] [Cited by in F6Publishing: 55] [Article Influence: 5.3] [Reference Citation Analysis]
19 Sotillo E, Barrett DM, Black KL, Bagashev A, Oldridge D, Wu G, Sussman R, Lanauze C, Ruella M, Gazzara MR, Martinez NM, Harrington CT, Chung EY, Perazzelli J, Hofmann TJ, Maude SL, Raman P, Barrera A, Gill S, Lacey SF, Melenhorst JJ, Allman D, Jacoby E, Fry T, Mackall C, Barash Y, Lynch KW, Maris JM, Grupp SA, Thomas-Tikhonenko A. Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy. Cancer Discov 2015;5:1282-95. [PMID: 26516065 DOI: 10.1158/2159-8290.CD-15-1020] [Cited by in Crossref: 604] [Cited by in F6Publishing: 350] [Article Influence: 86.3] [Reference Citation Analysis]